INTRODUCTION
Total Quality Management (TQM) is one of quality oriented approaches that many organizations adopt. It is generally acknowledged that manufacturing companies need to be quality oriented in conducting their business to survive the b u si n es s w or l d 1 . TQ M i s a n i n te gr a te d ma n a ge me nt p h il os op h y a n d a set of practices that emphasizes top management commitment, customer focus, supplier relationship, benchmarking, quality-oriented training, employee focus, zero-defects, process improvement, and quality measurement 2, 3 . As defined by ISO-"TQM is a management approach of an organization, centered on quality, based on the participation of all its members and aiming at longterm success through customer satisfaction, and benefits to all members of the organization and to society." TQM, combined with effective leadership, results in an organization doing the right things right, first time 4 . The application of TQM and its tools & techniques within a pharmaceutical industry not only improves its processes and Quality of products, but also adds a new step towards the overall improvement of the whole organization.
Actually in this paper, the detailed analysis was done on a pharmaceutical company. Almost all pharmaceutical companies use a highly improved technology and manufacturing processes. Hence they serve products of almost zero defects. But with the goal of achieving zero defects, they may not be so conscious of the production cost which can be reduced by applying TQM tools. Cost is one of the important dimensions of quality which is to be balanced with it for increased productivity and profit.
LITERATURE REVIEW
As the application of TQM tools & techniques within a pharmaceutical industry improves its processes and Quality of products with the overall improvement of the whole organization, it is important to introduce the tools.
These control chart is used to find out the inherent problems in the process when the process is actually in control.
CASE STUDY
Here all relevant data of this paper were collected from SQUARE PHARMACEUTICALS LIMITED, the leading manufacturer of pharmaceuticals in Bangladesh. SQUARE Cephalosporin's Limited (SCL) was built as a separate manufacturing plant at the kaliakoir site for Cephalosporine Antibiotics in 2006. They manufacture Cephalosporin's Antibiotics in various pharmaceutical dosage forms comprising tablets, capsules, dry powder for suspensions, pediatric drops etc. Among the huge list of their products Cefotil 500 Tablet is chosen for the detailed study.
Cefotil (Cefuroxime) is a well-characterized and effective antibacterial agent, which has broadspectrum bactericidal activity against a wide range of common pathogens. Cefotil 500 Tablet is a quick moving product but it need not to produce per day. Monthly almost eight batch is produced to meet the market demand. The batch size of Cefotil 500 Tablet is 65,000 tablets. The individual weight data of Cefotil 500 tablet is found from different inspection bench. Sample  5  924  932  954  956  954  956  944  942  951  944  954  947  963  933  963  948  952  955  946  945  973  959  941  954  939  955  961  954  976  952  973  983  940  962  955  949  970  953  947  943  959  963  958  959  949  959  937  947  948  958  950  960  956  962  949  945  953  959  964  957  959  963  971  962  955  936  954  955  961  950  970  959  947  952  960  955  964  940  956  964  975  952  968  955  958  951  952  957  956  951  957  944  960  954  946  950  952  966  959  953 They have some known defects as milling defects, compression defects, coating, thickness variation, blister packing etc. Among them almost all are in negligible amount in their view but this paper focus on the limits why certain defects are always negligible to them. All the defects are actually in negligible amounts and control limits used by them for the quality concern is also perfect. But in case of weight variation and thickness variation, they do not pay much heed in setting good control limits or other statistical quality control tools. This in turn increases its material cost (though tablet performance is perfect in work).
Here sample no is, N=20 Mean weight of every 100 Tablets= Weight (mg) of 100 tablets /100 Mean weight of every 100 Tablets = 95443/100 mg = 954.43 mg
Here the range for the weight of tablets are, Upper Limit = 966 mg, Lower Limit = 874 mg
The mean weight is assumed as the average weight of the 100 tablets. I.e. 954.43 mg.
The acceptable range is, Mean + 5% And not more than two shall deviate from this limit as well as the critical limit for acceptance is , Mean + 10% and none shall deviate from this limit.
Now standard deviation is calculated using The standard deviation of the thickness data is obtained using equation (i) and (ii) as, Ϭ = 0.04610398 Hence for the used range, upper limit is +3.85 ϭ & lower limit is -9.15 ϭ. This is shown in below figure. The control limits the Square Cephalosporin's Limited follows are shown in above calculations . The data reveals some important facts about their quality control tasks. 1. The weight and thickness of tablets are not same and the mean is based upon the obtained data average. Hence there is no standardized mean as well as mean may vary and can assume any value that is very much undesirable according to the sense of QUALITY. 2. The standard deviation obtained from these data is 9.77 for weight & 0.046 for thickness. Operating with these deviations respectively causes selection of wider control limit. Which may in turn show the in control situation when the process is actually out of control. 3.The next fact that which is almost clear to all is they do not maintain any ϭ limit which should obviously be narrowed for maintaining QUALITY and decreasing their material cost.
POSSIBLE IMPROVEMENTS In case of weight data
The first recommendation is to set a unique Mean. Let, µ = 945 mg The standard deviation obtained also is very large which can be narrowed to further quality improvement. The standard deviation may be , ϭ = 5 Here the limits are also wide but upper limits are less than before and constant as mean is constant. This can be improved by changing their concept of acceptable range in terms of % of mean to standard deviation concept.
Control chart using standard deviation concept
The control limits for the control chart are, 
Another control chart (X-bar and R chart)
Another control chart can be developed for variables. The chart is -R chart is given in Table 3 . Table 3 . Chart for calculating X-bar and R-bar 
The EWMA Control Chart
The EWMA is a special type of control chart which is capable of finding amy hidden errors of process.
The chart is built by a huge amount of calculations. For SQUARE datas the EWMA requires below calculations. For i = 1 Control Limit= = 954.43 
In case of thickness data
As the weight data, here the first recommendation is to set a unique Mean and standard deviation also. Let, µ = 6.35 mm And ϭ = .04 Here control charts using standard deviation concept, X-bar & R chart, EWMA control charts may be used for setting good control limits.
Control chart using standard deviation concept
The control limits for the control chart areUpper Control limit=µ + L ϭ = 6.35 + 3*0.04 = 6.47mm Lower control limit=µ -L ϭ = 6.35 -3*0.04 = 6.23
X-bar and R chart X-bar and R chart can also be constructed. The EWMA Control Chart As like as calculations of EWMA control chart for weight data, the control limit calculations are for observation no 1- Table 6 . Chart for calculating UCL, LCL and Z value
ANALYSIS OF OBTAINED CHARTS
The Control Charts and other charts including EWMA Control Charts shows that the datas belong to a large range. In different charts different circumstances are obvious-1. The range charts shows the datas are within the limit. But if we concentrate on the graph , it is clear that most of the datas are near to the upper range. Whereas they are far apart from lower range. It is desired for any process that data are to be clustered near the midlevel between two ranges. So that fault should be overcome by the process.And a more suitable range must be set. 2. The next graph of their (SCL's) calculated acceptance limit shows the very wider control limit. 3. The third graph shows the process acceptance limit is more than before.
4. The Control Chart for standard deviation shows a large amount of data falls beyond the control limit in case of weight data. Hence for those points process needs to be improved. 5. Another Control Chart (X-bar and R chart)
shows process within control limit but some points approaching towards the UCL & LCL. So the process needs to be improved to cluster the points towards CL. 6. The EWMA Control chart shows more improved control limit based on existing data. The limit is narrower, hence some points go beyond the acceptance limit in both case. So it is sure that if the process is more improved such that, all the data exists between the EWMA control limits then it is a highly reliable and improved process.
IMPROVEMENT BY FISHBONE DIAGRAM
There are some problems in Pharmaceutical companies , but these are very infrequent as occurs once in every six month or once in a year . So it can be said pharmaceutical companies are very much improved and quality focused. But here in this paper it is shown that they do not pay much heed on usage of excess material as a result the weights of antibiotics vary. The main or root causes behind the problem can be found by the Fishbone Diagram or Ishikawa Diagram.
Here the causes behind the weight and thickness variation may include lacking of man, machine, material, method and measurement etc. 1. Sometimes man may have faster operating tendency that causes weight variation. 2. The materials sometimes are less compressed. 3. Compression time for tablets may be not highly accurate. 4. There are no proper control limits for tablet weights. 5. The coating of tablets is not uniform in many times.
RECOMMENDATION
Some recommendations may be offered to SQUARE CEPHALOSPORINS LIMITED.
At first they can pay their attention on what
weighted & how much thick tablets they actually want. 2. Then they should concentrate on their control limit. 3. The control limit must be not in the way they currently follow. They should use Control Chart concept for the control limit selection. 4. The control limit can be narrowed and they can practice it for both antibiotic and hormonal tablets. Then they should concentrate on their control limit. 8. The control limit must be not in the way they currently follow. They should use Control Chart concept for the control limit selection. 9. The control limit can be narrowed and they can practice it for both antibiotic and hormonal tablets. 10. The thickness of coating on tablets should be reviewed. 11. The time to compress the tablets should be known by the all operators. 12. The operators must be motivated to perform jobs in time but not faster than required time. 13. The operating environment should be reviewed.
